Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

• Glavni autori: Haofeng Lu (Autor), Lin Zhou (Autor), Hongping Zuo (Autor), Wenjin Le (Autor), Jianfei Hu (Autor), Tiequan Zhang (Autor), Mi Li (Autor), Yufeng Yuan (Autor)
• Format: Knjiga
• Izdano: Wiley, 2022-06-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Abstract Advanced hepatocellular carcinoma (HCC) results in generally poor clinical outcomes and necessitates better therapeutic strategies. Ivermectin, which is an existing anti‐parasitic drug, has been recently identified as a novel anti‐cancer drug. In line with previous efforts, this work demons...